|
Recommend Cancer Biology & Therapy to your librarian for 2008. Download the form here.
Sign up for Table of Contents Alerts.
Table of Contentsjuly/august 2003 supplementvolume 2 |
|
Editor's Corner
Introductory Comments
Andrew C. von Eschenbach; Director, National Cancer InstituteVolume: 2 | Pages: S001-S001
Open Access Article
Review
Classical Chemotherapy: Mechanisms, Toxicities and the Therapeutc Window
Vikas Malhotra and Michael C. PerryVolume: 2 | Pages: S002-S004
Open Access Article
Targeting DNA Checkpoint Kinases in Cancer Therapy
Bin-Bing S. Zhou, Hilary J. Anderson and Michel RobergeVolume: 2 | Pages: S016-S022
Open Access Article
Cyclin E and Its Low Molecular Weight Forms in Human Cancer and as Targets for Cancer Therapy
Said Akli and Khandan KeyomarsiVolume: 2 | Pages: S038-S047
Open Access Article
E2F1 as a Target: Promoter-Driven Suicide and Small Molecule Modulators
William G. Kaelin, Jr.Volume: 2 | Pages: S048-S054
Open Access Article
Restoring p53-Dependent Tumor Suppression
Wenge Wang, Farzan Rastinejad and Wafik S. El-DeiryVolume: 2 | Pages: S055-S063
Open Access Article
Telomerase Promoter-Driven Cancer Cell Suicide
Jian Gu and Bingliang FangVolume: 2 | Pages: S064-S070
Open Access Article
TRAIL and Anti-Tumor Responses
Mahaveer Swaroop Bhojani, Brian D. Ross and Alnawaz RehemtullaVolume: 2 | Pages: S071-S078
Open Access Article
Inhibiting Tyrosine Kinases: Successes and Limitations
Carlos L. ArteagaVolume: 2 | Pages: S079-S083
Open Access Article
Novel Small Molecule Cyclin-Dependent Kinases Modulators in Human Clinical Trials
Adrian M. SenderowiczVolume: 2 | Pages: S084-S095
Open Access Article
Farnesyl Transferase Inhibitors: Mechanism of Action, Translational Studies and Clinical Evaluation
W. Robert Bishop, Paul Kirschmeier and Charles BaumVolume: 2 | Pages: S096-S104
Open Access Article
Targeting Bcl-2 Related Proteins in Cancer Therapy
Michael K. Manion and David HockenberyVolume: 2 | Pages: S105-S115
Open Access Article
Tumor Suppressing Gene Therapy
Bingliang Fang and Jack A. RothVolume: 2 | Pages: S115-S121
Open Access Article
Therapeutic Monoclonal Antibodies for the ErbB Family of Receptor Tyrosine Kinases
Hongtao Zhang, Mark Richter and Mark GreeneVolume: 2 | Pages: S122-S126
Open Access Article
Angiogenesis Inhibitors: A New Class of Drugs
Judah FolkmanVolume: 2 | Pages: S127-S133
Open Access Article
Human Tumor Xenografts as Predictive Preclinical Models for Anticancer Drug Activity in Humans: Better than Commonly Perceived—But They Can Be Improved
Robert S. KerbelVolume: 2 | Pages: S134-S139
Open Access Article
Chemopreventive Strategies Using NSAIDs and COX-2 Inhibitors
Josbert Keller and Francis GiardelloVolume: 2 | Pages: S140-S149
Open Access Article
Retinoid Targets in Cancer Therapy and Chemoprevention
Konstantin Dragnev, Jeffrey Petty and Ethan DmitrovskyVolume: 2 | Pages: S150-S156
Open Access Article
Cancer Specific Viruses and the Development of ONYX-015
Frank McCormickVolume: 2 | Pages: S157-S160
Open Access Article
Cancer Vaccines: An Old Idea Comes of Age
Leisha Emens and Elizabeth JaffeeVolume: 2 | Pages: S161-S168
Open Access Article
Novel Anticancer Agents in Clinical Development
Alex A. Adjei and Eric K. RowinskyVolume: 2 | Pages: S005-S015
Open Access Article
The Molecular Target of Rapamycin (mTOR) as a Therapeutic Target Against Cancer
Monica M. Mita, Alain Mita and Eric K. RowinskyVolume: 2 | Pages: S169-S177
Open Access Article
mda-7/IL-24, A Novel Cancer Selective Apoptosis Inducing Cytokine Gene: From the Laboratory into the Clinic
Paul B. Fisher, Rahul V. Gopalkrishnan, Sunil Chada, Rajagopal Ramesh, Elizabeth A. Grimm, Myrna R. Rosenfeld, David T. Curiel and Paul DentVolume: 2 | Pages: S023-S037
Open Access Article
Editor's Corner
Cover Image
NAVolume: 2 | Pages: S001-S001
Open Access Article
Research Philosophy
New Paradigms for Cancer Drug Discovery?
Jason A. Sager and Christoph LengauerVolume: 2 | Pages: S178-S181